Close

Human Genome Sciences, Inc. (HGSI) Misses Q2 EPS by 1c

July 21, 2011 4:12 PM EDT
Human Genome Sciences, Inc. (NASDAQ: HGSI) reported Q2 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $24.9 million versus the consensus estimate of $29.03 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings